Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
US Department of Justice
Fish and Richardson
Colorcon
Julphar
AstraZeneca
Deloitte
Harvard Business School
US Army
Cerilliant

Generated: August 17, 2017

DrugPatentWatch Database Preview

BACITRACIN-NEOMYCIN-POLYMYXIN Drug Profile

« Back to Dashboard

What is the patent landscape for Bacitracin-neomycin-polymyxin, and when can generic versions of Bacitracin-neomycin-polymyxin launch?

Bacitracin-neomycin-polymyxin is a drug marketed by Pharmaderm, Altana, and Perrigo Co Tennessee. and is included in three NDAs.

The generic ingredient in BACITRACIN-NEOMYCIN-POLYMYXIN is bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.

Summary for Tradename: BACITRACIN-NEOMYCIN-POLYMYXIN

Patents:0
Applicants:3
NDAs:3
Clinical Trials: see list55
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BACITRACIN-NEOMYCIN-POLYMYXIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm
BACITRACIN-NEOMYCIN-POLYMYXIN
bacitracin zinc; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC062167-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Altana
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC060731-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Perrigo Co Tennessee
BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE
bacitracin; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate
OINTMENT;OPHTHALMIC062166-002Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Chinese Patent Office
Deloitte
Boehringer Ingelheim
QuintilesIMS
McKesson
Healthtrust
Express Scripts
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot